| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |